Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy

Front Immunol. 2018 Dec 5:9:2878. doi: 10.3389/fimmu.2018.02878. eCollection 2018.

Alexandr V Bazhin^{1

2}, Amedeo Amedei^{3

4}, Svetlana Karakhanova^{5

6}

¹ Department of General, Visceral, and Transplantation Surgery, Ludwig-Maximilians University, Munich, Germany.
² Partner Site Munich, German Cancer Consortium (DKTK), Munich, Germany.
³ Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
⁴ Neuromusculoskeletal Department (Interdisciplinary Internal Medicine), Azienda Ospedaliera Universitaria Careggi, Florence, Italy.
⁵ Section Surgical Research, University of Heidelberg, Heidelberg, Germany.
⁶ Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

No abstract available

Keywords: CTLA-4 (CD152); PD-1 (CD279); PDL1; cancer immunotherapy; immune checkpoint molecules.

Publication types